Burrill Starts Prana Biotechnology (PRAN) at Market Outperform – StreetInsider.com (subscription)
By Dr. Matthew Watson
Burrill Starts Prana Biotechnology (PRAN) at Market Outperform StreetInsider.com (subscription) The firm comments, "We are initiating coverage on Prana Biotechnology, that is developing a platform technology to address the potential causes of neurodegenerative disorders. Prana is undervalued relative to its peer group, in our view." "We believe ... |
Uncategorized
Comments Off on Burrill Starts Prana Biotechnology (PRAN) at Market Outperform – StreetInsider.com (subscription) |
December 23rd, 2012
This author published 5852 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research